Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma
- 28 January 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (4), 1007-1014
- https://doi.org/10.1038/sj.onc.1202384
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 26 references indexed in Scilit:
- TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosisOncogene, 1997
- K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancerBritish Journal of Cancer, 1997
- Prognostic Significance of p53 andrasGene Abnormalities in Lung Adenocarcinoma Patients with Stage I Disease after Curative ResectionJapanese Journal of Cancer Research, 1994
- Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphismGenes, Chromosomes and Cancer, 1992
- Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.Proceedings of the National Academy of Sciences, 1991
- p53 Mutations in Human CancersScience, 1991
- Evidence implicating at least two genes on chromosome 17p in breast carcinogenesisThe Lancet, 1990
- Increased expression of mutant forms of p53 oncogene in primary lung cancerThe Lancet, 1990
- The p53 proto-oncogene can act as a suppressor of transformationCell, 1989
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989